273
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Improvement in treatment results of glioblastoma over the last three decades and beneficial factors

, , , , , , , , , , , , , , , & show all
Pages 206-212 | Received 25 Mar 2014, Accepted 14 Sep 2014, Published online: 14 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maria Eriksson, Jenna Kahari, Amanda Vestman, Mattias Hallmans, Mikael Johansson, A. Tommy Bergenheim & Maria Sandström. (2019) Improved treatment of glioblastoma – changes in survival over two decades at a single regional Centre. Acta Oncologica 58:3, pages 334-341.
Read now
Khaled Greish, Anfal Jasim, Neha Parayath, Sara Abdelghany, Ali Alkhateeb, Sebastien Taurin & Hayley Nehoff. (2018) Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme. Journal of Drug Targeting 26:8, pages 692-708.
Read now

Articles from other publishers (14)

Eduardo Erasmo Mendoza Mireles, Erlend Skaga, Andres Server, Henning Leske, Petter Brandal, Eirik Helseth, Pål A Rønning & Einar O Vik-Mo. (2023) The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study. Neuro-Oncology Practice 10:6, pages 555-564.
Crossref
Diogo Alpuim Costa, Mafalda Sampaio-Alves, Eduardo Netto, Gonçalo Fernandez, Edson Oliveira, Andreia Teixeira, Pedro Modas Daniel, Guilherme Silva Bernardo & Carla Amaro. (2022) Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma—A Scoping Review. Frontiers in Neurology 13.
Crossref
Maureen Keller, Magdalena Blom, Lei Liu Conze, Min Guo, Daniel Hägerstrand & Pontus Aspenström. (2022) Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes. Scientific Reports 12:1.
Crossref
Yu-ying Lei, Yi-tong Li, Qi-lu Hu, Juan Wang & Ai-xia Sui. (2019) Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis. World Journal of Surgical Oncology 17:1.
Crossref
Abdul Qawee Mahyoob Rani, Kazuhiro Maeta, Tatsuya Kawaguchi, Hiroyuki Awano, Masashi Nagai, Hisahide Nishio & Masafumi Matsuo. (2019) Schwann cell-specific Dp116 is expressed in glioblastoma cells, revealing two novel DMD gene splicing patterns. Biochemistry and Biophysics Reports 20, pages 100703.
Crossref
Wen-Lei Wang, Na Aru, Zhi Liu, Xun Shen, Yi-Ming Ding, Shi-Ju Wu, Huai-Hai Qin & Wen-Yi Jin. (2019) Prognosis of patients with newly diagnosed glioblastoma treated with molecularly targeted drugs combined with radiotherapy vs temozolomide monotherapy. Medicine 98:45, pages e17759.
Crossref
Abdul Qawee Mahyoob Rani, Manal Farea, Kazuhiro Maeta, Tatsuya Kawaguchi, Hiroyuki Awano, Masashi Nagai, Hisahide Nishio & Masafumi Matsuo. (2019) Identification of the shortest splice variant of Dp71, together with five known variants, in glioblastoma cells. Biochemical and Biophysical Research Communications 508:2, pages 640-645.
Crossref
Victor M. Lu, Pavlos Texakalidis, Kerrie L. McDonald, Rania A. Mekary & Timothy R. Smith. (2018) The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis. Clinical Neurology and Neurosurgery 174, pages 149-155.
Crossref
Sabrina Kröger, Ann-Christin Niehoff, Astrid Jeibmann, Michael Sperling, Werner Paulus, Walter Stummer & Uwe Karst. (2018) Complementary Molecular and Elemental Mass-Spectrometric Imaging of Human Brain Tumors Resected by Fluorescence-Guided Surgery. Analytical Chemistry 90:20, pages 12253-12260.
Crossref
�zlem Yersal, Eylem Odabaşi, �zge �zdemir & Yasemin Kemal. (2018) Prognostic significance of pre‑treatment neutrophil‑to‑lymphocyte ratio and platelet‑to‑lymphocyte ratio in patients with glioblastoma. Molecular and Clinical Oncology.
Crossref
Hirofumi Hirano, Takashi Kawahara, Masaki Niiro, Hajime Yonezawa, Tomoko Takajyou, Yasuyo Ohi, Ikumi Kitazono, Kiyohiro Sakae & Kazunori Arita. (2017) Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report. Molecular and Clinical Oncology 6:3, pages 321-326.
Crossref
Rachel Grossman, Nir Shimony, Dror Shir, Tal Gonen, Razi Sitt, Tali Jonas Kimchi, Carmit Ben Harosh & Zvi Ram. (2016) Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival. Annals of Surgical Oncology 24:3, pages 794-800.
Crossref
Hajime Yonezawa, Hirofumi Hirano, Hiroyuki Uchida, Mika Habu, Ryosuke Hanaya, Tatsuki Oyoshi, Yuko Sadamura, Tomoko Hanada, Hiroshi Tokimura, Fm Moinuddin & Kazunori Arita. (2017) Efficacy of bevacizumab therapy for unresectable malignant glioma: A retrospective analysis. Molecular and Clinical Oncology 6:1, pages 105-110.
Crossref
Jiahao Su, Meiqin Cai, Wensheng Li, Bo Hou, Haiyong He, Cong Ling, Tengchao Huang, Huijiao Liu & Ying Guo. (2016) Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 24:2, pages 117-128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.